Related Experiment Video
Updated: Jul 16, 2026
12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Five years experience of predictive testing for myotonic dystrophy using linked DNA markers
W Reardon1, J L Floyd, J Myring
1Institute of Medical Genetics, University Hospital of Wales, Heath Park, Cardiff.
American Journal of Medical Genetics
|August 1, 1992
Summary
Molecular diagnostic services for myotonic dystrophy (DM) offer valuable insights. Combining genetic testing with clinical evaluation is crucial for accurate diagnosis and minimizing errors in genotype assignment.
Area of Science:
- Genetics
- Molecular Diagnostics
- Neuromuscular Disorders
Background:
- Myotonic dystrophy (DM) is an inherited neuromuscular disorder.
- Presymptomatic and prenatal molecular diagnostic services are essential for affected families.
- Closely linked markers are utilized for genetic analysis.
Observation:
- A 5-year experience with 235 molecular diagnostic results from 161 families was analyzed.
- A low rate of uninformative (4.3%) and unreportable (1.9%) genetic analyses was observed.
- Clinical assessment identified individuals at low genetic risk who were actually at high risk for DM.
Findings:
- Molecular testing for myotonic dystrophy is highly informative.
- Clinical evaluation is critical for interpreting molecular results accurately.
- Discrepancies between clinical risk assessment and molecular findings highlight the need for integrated diagnostics.
Implications:
- Accurate diagnosis of myotonic dystrophy relies on a combination of molecular and clinical data.
- Molecular diagnostics, when integrated with clinical expertise, can improve diagnostic accuracy.
- This approach minimizes errors in genotype assignment and aids in patient management.
